Full Text View
Tabular View
No Study Results Posted
Related Studies
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
This study has been completed.
Study NCT00628719   Information provided by Banaras Hindu University

First Received on February 20, 2008.   Last Updated on April 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Visceral Leishmaniasis
Additional conditions recognized in this trial
Leishmaniasis
Leishmaniasis, Visceral
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
Liposomal Amphotericin B
amphotericin B deoxycholate
Additional drug interventions recognized in this trial
Amphotericin B
Amphotericin B, deoxycholate drug combination
Deoxycholic Acid
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Cholagogues and Choleretics
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Banaras Hindu University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services